Global Respiratory Measuring Devices Market Size By Type (Pulse Oximeters, Spirometers), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Respiratory Measuring Devices Market was valued at USD 6.1 billion in 2023 and is projected to reach USD 10.4 billion by 2031, expanding at a CAGR of 6.9% during the forecast period of 2023–2031. This growth is primarily attributed to the increasing prevalence of respiratory disorders such as asthma, COPD, and sleep apnea, along with rising awareness about early diagnosis and respiratory health monitoring. Additionally, the shift towards home-based healthcare and the incorporation of digital health technologies in respiratory monitoring are further accelerating market growth globally.

Drivers:

1. Rising Prevalence of Respiratory Disorders:

The global burden of chronic respiratory diseases is growing, driven by factors like air pollution, tobacco consumption, and aging populations. This is boosting the demand for accurate and portable respiratory measuring devices.

2. Shift Toward Home Healthcare:

The growing emphasis on patient-centric care and remote monitoring is fueling the adoption of portable respiratory devices for home use, especially among geriatric patients and those with chronic respiratory illnesses.

3. Technological Advancements:

Integration of smart sensors, Bluetooth connectivity, and AI-powered analytics is enhancing the functionality and user experience of respiratory measuring devices, making them more reliable and user-friendly.

Restraints:

1. High Costs and Limited Reimbursement:

Advanced respiratory monitoring systems can be expensive, and inconsistent reimbursement policies across regions may hinder adoption, particularly in developing markets.

2. Lack of Awareness and Skilled Professionals:

In low-resource settings, the lack of awareness about respiratory health and limited availability of trained healthcare providers can restrict market growth.

Opportunity:

1. Emerging Markets and Telemedicine Integration:

The rapid development of healthcare infrastructure in emerging economies, coupled with the integration of respiratory diagnostics into telemedicine platforms, presents substantial growth opportunities.

2. Innovation in Wearable Respiratory Monitors:

R&D focused on non-invasive and wearable respiratory measuring technologies is expected to unlock new applications in both clinical and home settings.

Market by System Type Insights:

Based on system type, the Spirometers segment held the largest market share in 2023. Spirometers are extensively used for diagnosing and monitoring asthma, COPD, and other pulmonary conditions due to their efficiency and ease of use. Meanwhile, peak flow meters are witnessing growing demand in home-based settings, and capnographs are gaining popularity in surgical and critical care environments.

Market by End-use Insights:

In 2023, the Hospitals segment emerged as the largest end-use market, driven by the high volume of respiratory assessments performed in clinical settings. However, the Homecare segment is expected to register the highest growth rate during the forecast period due to increasing adoption of remote patient monitoring and the preference for home-based chronic care solutions.

Market by Regional Insights:

North America dominated the market in 2023, backed by well-established healthcare systems, a high prevalence of respiratory diseases, and substantial investment in healthcare technology. The Asia-Pacific region is forecasted to grow at the fastest rate, propelled by a large patient base, expanding healthcare access, and growing awareness of respiratory conditions in countries like China and India.

Competitive Scenario:

Key players in the Global Respiratory Measuring Devices Market include Philips Healthcare, ResMed Inc., Vyaire Medical Inc., Medtronic plc, Hillrom (now part of Baxter), Smiths Medical, Nihon Kohden Corporation, and Vitalograph Ltd. These companies are focusing on expanding their product portfolios, integrating digital health features, and engaging in strategic mergers and acquisitions to strengthen their global presence.

Key Market Developments:

In 2023, ResMed introduced a cloud-connected spirometer for real-time monitoring in telehealth settings.

In 2024, Philips launched an advanced wearable respiratory monitor incorporating AI-driven analytics.

In 2025, Vyaire Medical partnered with a major hospital network in Europe to deploy wireless capnography systems for post-operative care.

Scope of Work – Global Respiratory Measuring Devices Market

Report Metric Details

Market Size (2023) USD 6.1 billion

Projected Market Size (2031) USD 10.4 billion

CAGR (2023–2031) 6.9%

Market Segments By System Type (Spirometers, Peak Flow Meters, Capnographs), By End-use (Hospitals, Homecare, Ambulatory Surgical Centers)

Growth Drivers Rise in respiratory disease burden, homecare adoption, tech innovations

Opportunities Telemedicine integration, wearable respiratory monitors

FAQs:

1) What is the current market size of the Global Respiratory Measuring Devices Market?

The market was valued at USD 6.1 billion in 2023.

2) What is the major growth driver of the Global Respiratory Measuring Devices Market?

The rising prevalence of chronic respiratory disorders and increasing adoption of home-based monitoring devices.

3) Which is the largest region during the forecast period in the Global Respiratory Measuring Devices Market?

North America holds the largest market share due to advanced healthcare infrastructure and technology adoption.

4) Which segment accounted for the largest market share in Global Respiratory Measuring Devices Market?

The Spirometers segment dominated the market in 2023.

5) Who are the key market players in the Global Respiratory Measuring Devices Market?

Philips Healthcare, ResMed Inc., Vyaire Medical Inc., Medtronic plc, Hillrom, Smiths Medical, Nihon Kohden Corporation, and Vitalograph Ltd.